Highlights in BioScience ISSN:2682-4043 DOI:10.36462/H.BioSci.202102 Research Article Open Access 1 Department of Biomedical Laboratory Sciences , Kibogora Polytechnic, Rwanda. 2 Biomedical Laboratory Sciences Dept, INES Ruhengeri-Institute of Applied Sciences, Rwanda. Contacts of authors * To whom correspondence should be addressed: Yadufashije Callixte Received: May 30, 2020 Accepted: November 2, 2020 Published: January 16, 2021 Citation: Fulgence M, Joseph M, Callixte Y, William N . Renal dysfunction among HIV patients under highly active antiretroviral therapy attending Kibagabaga district. 2021 Jan 16;4:bs202102 Copyright: © 2021 Fulgence et al.. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability Statement: All relevant data are within the paper and supplementary materials. Funding: The authors have no support or funding to report. Competing interests: The authors declare that they have no competing interests. Renal dysfunction among HIV patients under highly active antiretro- viral therapy attending Kibagabaga district Munyandamutsa Fulgence1, Mucumbitsi Joseph2, Yadufashije Callixte*2, Niyonzima William2 Abstract Antiretroviral therapy is used for the suppression of the HIV virus and stops its progres- sion to cause disease. Despite its role, it has the pathophysiologic effect to kidney function for users. The study was conducted to evaluate the renal function for HIV patients under highly active antiretroviral therapy at Kibagabaga District Hospital. Venous blood samples (4mL) were collected by vein puncture in phlebotomy services by means of the dry tubes from 170 patients under antiretroviral therapy. Blood samples were transported to clinical biochemistry department for analysis. Rotor centrifuge was used to separate the serum and other blood components; creatinine level was analysed for renal function analysis. The total of 170 HIV patients were considered in the study. Of the 170, 50 HIV patients were used for primary data collection, while 120 HIV patients who previously received antiretroviral therapy were considered as secondary data collection source. The patients between 25-45 years old have experienced the highest level of abnormal concentration of renal tests 25%, patients with above 45 years old was ranked the second to have the abnormal level (14.2%). Females were 59% and have experienced the high risk of renal dysfunction than males, the level of glomerular filtration rate was 67 (39.4%), and was higher than creatinine 42 (24.7%). Antiretroviral therapy has a negative effect on kidneys. Abnormalities of the kidney parameters were prevalently high among both male and female. The serious follow is needed for this vulnerable population. Keywords: Renal function, HIV, HAART, Estimated glomerular filtration rate Introduction Human immunodeficiency virus (HIV) infection mostly provoke acute or chronic renal proximal renal tubule resulting in functional disturbance with mitochondrial injury being one of the most important targets [1]. It results to the failure of excretory functions of kidney, which is disease and people are living longer. HIV infection negative side effects might lead to the heart, lungs, and renal diseases, which could cause high mortality among HIV patients. Africa endures greater than 60% of the global burden of HIV, however, characterized by decrease in glomerular filtration rate [2]. The advances in development of Highly active antiretroviral therapy (HAART) is a high risk to the development of the serious renal disease in developed world with very few studies done in developing world [3]. Kidney function has been estimated to be abnormal up to 30% of all HIV patients. Few outpatient renal screening studies from Africa describe varying prevalence from as low 6% to a high of 50% [4]. The dysfunction of the kidney is medical kidney abnormality where this important organ gets impairment for the filtration of wastes from blood [5]. Nephropathy is one of the complications characterizing the kidney dysfunction for HIV patients [6]. Kidney disease was clinically diagnosed considering the presence of albuminuria but also low estimated glomerular filtration rate [7]. Some antiretroviral agents can cause serious side effects that affect multiple systems; including the kidneys Tenofovir (tenofovir disoproxil fumarate) and this could be associated with development of the acute renal failure (ARF) and the dysfunction of proximal and distal tubules [8]. Highlights in BioScience Page 1 of 4 January 2021|Volume 4 https://doi.org/10.36462/H.BioSci.202102 https://creativecommons.org/licenses/by/4.0/ http://highlightsin.org/index.php/bioscience Fulgence et al., 2021 Renal dysfunction among HIV patients under antiretroviral therapy The first described patient who was treated with tenofovir and developed reversible Fanconi syndrome, nephrogenic dia- betes insipidus and ARF, Renal biopsy demonstrated cytoplasmic vacuolization, apical localization of nuclei and reduction of the brush border on proximal tubule epithelial cells [9]. Materials and Methods Study area description The study was conducted at Kibagabaga district hospital. Kibagabaga district hospital is located in Kigali city, Nyaru- genge district; the hospital receives the referred patients from 16 health centers of Nyarugenge from neighbouring health canters in Gasabo and kicukiro. Study design Both cross-sectional and retrospective study design were used. The study was carried out from October to December 2019. Study population and sample size All HIV patients under highly active antiretroviral therapy attending Kibagabaga District hospital during the period will be targeted by the study. However, only patients who were not HIV positive did not participate. The population size was 170; the sample size was determined by the number of eligible patients who attended the Hospital and accepted to participate in the study during the period of the study. Collection of stool sample Blood samples were collected with phlebotomy and biochem- istry SOPs support. The patients were placed in a comfortable seat and requested to remove sleeves from the part of the arm. Phlebotomist finds the arm with visible fuller vein. A stretched band tourniquet was placed around the upper arm to help the vein bloat. The place for injection was then whipped with cotton after being soaked in the antiseptic solution. The needle was slightly inserted into the swollen vein and around 4ml of blood were collected by the help of a seal dry test tube. Specimen containers or collection devices was labelled with the patient record number was recorded along with the date of birth to avoid bias and errors in laboratory results. Sample processing The sample collection and processing were done according to Kibagabaga District Hospital laboratory SOPs, the tubes con- taining blood was taken to clinical biochemistry department. The collected blood specimen was clotted for 15 min before centrifu- gation at 3000 rpm for 5 minutes using a rotor centrifuge for separation of serum and other blood components. Creatinine level was analysed for renal function by using automated bio- chemistry machines (Architecture machine or Cobasc311), the Cobas C311. Data analysis After data collection, the SPSS version 23.0 program and excel 2016 was used for data analysis. To compare variables and association between renal function in HIV patients under HAART and its clinical manifestastion unduced by this medication,and prevalence Ethical considerations This study was conducted after obtaining an ethical approval from Kibogora Polytechnic research committee. In addition, the authorization was requested from Kibagabaga District hospital, Clinical research and office of education before conducting this research. The purpose of research project, sample collection procedures, as well as confidentiality of research results was explained to participants. Participation was voluntarily after understanding the aim and expect outcome of research. There was no expected risks that can threaten the lives of participants. Results Social demographic characteristics of study population In this study the social demographic characteristics of the study population were established to characterize the population, Table 1 indicates the analysis which was done on 170 HIV paa- tients under highly active antiretroviral therapy from Kibagabaga district Hospital in a period of 3 mounths. Table 1 reveals the different parameters with renal function tests such as age group, gender, period, clinical manifestation and weight. The high fre- quency was observed in the age group between 25-45 years old. The number of females stood at 62%, mouth ulcers predominated the clinical manifestations with percentage of 29.4% followed by memory loss at 25%. Over weight patients stood at 6.5% while 38.8% was in normal ranges. Table 2 shows the range of of creatinine and Glomerular filtration rate level according sex. Clinical analyses In this study the creatinine level and glomerular filtration rate showed the high prevalence of abnormal results in males with 14.5% and 39.4 respectively. Cross sectional and retrospective studies were assessed and shown in Table 3; the majority of patients were females with 28 (56%) and 22 (44%) were males. Moreover, in retrospective 29 (58%) were females and 22 (18.3%) were males. Table 4 shows diagnosed patients based on clinical symptoms associated to renal dysfunction in HIV patients; the majority of patients was those with mouth ulcers 50 (28.6%) followed by memory loss with 43 (24.6%). Discussion This study analysed biochemical parameters of HIV patients under highly active antiretroviral therapy, this medication leads to the serious side effects including kidney failure for patients under those medications. This study considered the level of creatinine and estimation of glomerular filtration rate as tests to confirm the renal function of HIV patients under highly active antiretroviral therapy. Highlights in BioScience Page 2 of 4 January 2021|Volume 4 http://highlightsin.org/index.php/bioscience Fulgence et al., 2021 Renal dysfunction among HIV patients under antiretroviral therapy Table 1. Number of patients participated in the study and their corresponding gender, age, clinical manifestation, weight and period. Parameter Variables Frequency Percentages % Age groups [5-25] Years 13 9.6 [25-45] Years 93 54.7 Above 45 Years 64 37.6 Sex Males 64 38 Females 106 62 Period 2018 retrospective 70 41.2 2019 prospective 50 29.4 2019 retrospective 50 29.4 Clinical manifestation Night sweats 18 10.6 Weight loss 19 11.2 Depression 40 23.5 Mouth ulcers 50 29.4 memory loss 43 25.3 Weight 40-60 kg 38 22.4 60-80 kg 66 38.8 80-100 kg 55 32.4 Above 100 kg 11 6.5 Total 170 100 Table 2. Number of patients participate the study and their corresponding results according to gender. State Creatinine level (Mg/dl) eGFR (Ml/min) Females Males Total Females Males Total Normal 92 (54.1) 36 (21.2) 128 (75.3) 7 2(38.4) 31 (22.2) 103 (60.6) Abnormal 17 (10.2) 25 (14.5) 42 (24.7) 32 (16.1) 35 (23.3) 67 (39.4) Table 3. Prevalence of abnormal Creatinine and EGFR according to age and gender in suspected patients at KDH, where the creatinine (kg/dl) (A), EGFR (ml/min)(B), and Prevalence (%)(C) are shown. Groups Variables Cross sectional study N (50) Retrospective study N (120) (A) (B) (C) (A) (B) (C) Age groups 5-25 1 (2) 1 (2) 8% 0 (0) 2 (1.6) 13% 25-45 6 (12) 11 (22) 68% 15 (12.5) 22 (18.3) 25% Above 45 2 (4) 3 (6) 2% 17 (14.1) 28 (23.3) 14.20% Gender Females 20 (40) 28 (56) 48% 16 (13.3) 29 (58) 59% Males 22 (44) 14 (28) 36% 17 (14.1) 22 (18.3) 27% Table 4. Clinical Manifestation and their associated abnormal level of renal test. The frequency (%) of occurrence of symptoms The frequency (% ) of renal dysfunction Clinical manifestation Frequency (%) Abnormal creatinine Abnormal EGFR Nigth sweats 18 (10.3%) 6 (3.5%) 7 (4.1%) Weight loss 19 (10.9%) 9 (5.2%) 9 (5.2%) Depression 40 (22.9) 5 (2.9%) 13 (7.6%) Mouth ulcers 50 (28.6) 14 (8.2%) 25 (14.7%) Memory loss 43 (24.6%) 9 (5.2%) 13 (.6%) Among 170 suspected patients, 64(38%) were males and 106 (62%) females. The mean age of the population was 56.6, and the standard deviation of age was 40.5. 54.7% of patients were in the age range of [25-45] Years, and were the majority in the study participants. this age is at high risk because of the habit of doing unprotected sex than elderly age. After testing creatinine level and Egfr the results showed the normal females 38.4% and 23.3% males with abnormal eGFR level and abnormal creatinine respectively. The study conducted on active antiretroviral therapy among HIV patients shows no difference with the current study since it revealed the high Glomerular filtration rate (EGFR) and creatinine in females than males under highly active antiretroviral therapy [12] The patients who had positive test results with crea- tinine and eGFR for cross-section study, the findings show that the majority of patients were females with 28(56%) and 22(44%) were males. Moreover, in the retrospective 29(58%) were fe- males and 22 (18.3%) were males. In addition, the prevalence of renal dysfunction was high in old age in females. these results were comparable to the findings of Willems and his colleagues [13], we estimated the prevalence of eGFR and mortality risks in a population-based study of persons aged 85 years and older, based on these results. The patients were diagnosed based on clinical symptoms associated with renal function of HIV patients. The majority of patients induced the mouth ulcers 50 (28.6) than other clin- ical manifestation. The results showed that there is significant relationship between the most of clinical manifestation and re- nal function of HIV patients under highly active antiretroviral therapy. The similar findings were reported where self-reported strategies used by persons living with HIV/AIDS and their clini- cal manifestation induced by ART such us moth ulcers, weight loss and other opportunist infections were described [14]. Conclusions The study confirmed the effect of antiretroviral therapy on kidneys where the abnormalities of creatinine and eGFR were more prevalent 59% and 27% in both females and males respec- tively. It is a paramount action of treating patients to enhance the longevity even if renal dysfunction may occur. All HIV patients under retroviral therapy should be followed up to maintain the normal function of the kidneys. Acknowledgement We are with pleasure to thank Kibagabaga distict hospital’s authorities to allow the study to be conducted in the hospital facilities and their abundant generosity. In addition, we once again address our thanks to Kibogora Polytechnic for its vision of promoting research not only in the region but also all over the world. References 1. Hilton R. Human immunodeficiency virus infection and kid- ney disease. J R Coll Physicians Edinb 2013; 43(3):236-40. http://dx.doi.org/10.4997/JRCPE.2013.310 2. Authier FJ, Chariot P, Gherardi RK. Skeletal muscle involvement in human immunodeficiency virus (HIV)–infected patients in the era of highly active antiretroviral therapy (HAART). Mus- Highlights in BioScience Page 3 of 4 January 2021|Volume 4 http://highlightsin.org/index.php/bioscience Fulgence et al., 2021 Renal dysfunction among HIV patients under antiretroviral therapy cle and Nerve: Official Journal of the American Association of Electrodiagnostic Medicine. 2005 Sep;32(3):247-60. 3. Gray F, Keohane C. The neuropathology of HIV infection in the era of highly active antiretroviral therapy (HAART). Brain pathology. 2003 Jan;13(1):79-83. 4. Campbell C, Nair Y, Maimane S, Nicholson J. Dying Twice’ A Multi-level Model of the Roots of AIDS Stigma in Two South African Communities. Journal of health psychology. 2007 May; 12(3): 403-16. 5. Matiyashchuk IG, Amosova KM, Iaremenko OB, Zakharova VI, Koliadenko DI. Impaired endothelial vasoregulatory function in patients with systemic lupus erythematosus: association with renal involvement, inflammatory markers, and autoantibodies. KIDNEYS. 2020;9(1):14-9. 6. Núñez M, Saran AM, Freedman BI. Gene-gene and gene- envi- ronment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene. Advances in chronic kidney disease. 2010 Jan 1;17(1):44-51. 7. Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ. Chronic kidney disease. Nature reviews Disease primers. 2017 Nov 23;3(1):1-24. 8. Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD, EuroSIDA Study Group. Chronic renal failure among HIV-1-infected pa- tients. Aids. 2007 May 31;21(9):1119-27. 9. Badowski ME, Burton B, Shaeer KM, Dicristofano J. Oral on- colytic and antiretroviral therapy administration: dose adjust- ments, drug interactions, and other considerations for clinical use. Drugs in context. 2019;8. 10. Myers GL. Standardization of serum creatinine measurement: theory and practice. Scandinavian Journal of Clinical and Labo- ratory Investigation. 2008 Jan 1;68(sup241):57-63. 11. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clinical Journal of the American Society of Nephrology. 2010 Jun 1;5(6):1003-9. 12. Overton, ET., Wyatt, CM., Mitsuyasu, RT., Wensing, A. M., Calvez, V., Günthard, H. F. and Richman, DD. Topics in Antiviral Medicine. 2014;40(10):100-109. 13. Willems JM, Vlasveld T, den Elzen WP, Westendorp RG, Ra- belink TJ, de Craen AJ, Blauw GJ. Performance of Cockcroft- Gault, MDRD, and CKD-EPI in estimating prevalence of renal function and predicting survival in the oldest old. BMC geriatrics. 2013 Dec 1;13(1):113. 14. Sukati NA, Mndebele SC, Makoa ET, Ramukumba TS, Makoae LN, Seboni NM, Human S, Holzemer WL. HIV/AIDS symptom management in Southern Africa. Journal of Pain and Symptom Management. 2005 Feb 1;29(2):185-92. Highlights in BioScience Page 4 of 4 January 2021|Volume 4 http://highlightsin.org/index.php/bioscience Abstract Introduction Materials and Methods Study area description Study design Data analysis Ethical considerations Results Social demographic characteristics of study population Clinical analyses Discussion Conclusions Acknowledgement References